Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jan;86(1):237-41.
doi: 10.1073/pnas.86.1.237.

Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice

Affiliations

Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice

R Reuter et al. Proc Natl Acad Sci U S A. 1989 Jan.

Abstract

Autoantibodies to nucleolar components are a common serological feature of patients suffering from scleroderma, a collagen vascular autoimmune disease. While animal models, which spontaneously develop abundant anti-nucleolar antibodies, have not yet been described, high titers of such antibodies may be induced by treating susceptible strains of mice with mercuric chloride. We have identified the nucleolar autoantigen against which the HgCl2-induced IgG autoantibodies from mice of strain B10.S are directed. It is a protein with an apparent molecular mass of 36 kDa and a pI value of approximately 8.6, which is associated with the nucleolar small nuclear RNA U3, and by these criteria must be identical with a polypeptide called fibrillarin. It is striking that scleroderma patients spontaneously produce autoantibodies against the same U3 ribonucleoprotein (RNP). The HgCl2-induced murine and the scleroderma-specific human anti-U3 RNP autoantibodies were indistinguishable in their reactivities toward fibrillarin. They further resemble each other insofar as both recognize epitopes on the 36-kDa protein, which have been highly conserved throughout evolution. Our results provide a basis to investigate at the molecular level whether similar immunoregulatory dysfunctions may lead to the preferential anti-U3 RNP autoantibody production in the animal model and in scleroderma patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arthritis Rheum. 1985 Feb;28(2):226-30 - PubMed
    1. Clin Exp Immunol. 1984 Nov;58(2):300-6 - PubMed
    1. J Biol Chem. 1985 Nov 15;260(26):14304-10 - PubMed
    1. Biol Cell. 1985;54(2):123-33 - PubMed
    1. J Immunol. 1986 Oct 15;137(8):2548-54 - PubMed

Publication types